Moody’s revises Mount Sinai Hospital’s outlook to stable

Moody’s Investors Service affirmed the “A3” rating on New York City-based Mount Sinai Hospital, affecting approximately $315 million in bonds.

Advertisement

The ratings affirmation is based on a number of factors, including the hospital’s strong market position as a reputable academic medical center.

The outlook was revised to stable from negative, reflecting Moody’s Investors Service’s favorable opinion of MSH’s improved operating performance and the overall notable liquidity growth at system hospitals following sizeable asset sales.

More articles on healthcare finance:
7 recent hospital outlook and credit rating actions
Fitch affirms ‘A-‘ rating on Winchester Hospital’s bonds
5 most-read finance stories: Week of May 1-5

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.